A 13-year-old Australian boy named Harry Booth has spent much of the winter shuttling between home and hospital, fighting chest and urinary tract infections that his doctors struggle to treat. Harry was born with kidney failure, started dialysis at six months old, and received a kidney transplant from his father at age four. The surgery saved his life but forced him onto immune-suppressing drugs to prevent organ rejection. Now, even common bugs are becoming dangerous for him.
A global study tracks a decade and a half of rising resistance
A new study spanning 82 countries found that antibiotic resistance in children increased in every region of the world between 2004 and 2022. Researchers analyzed data on common infections such as urinary tract infections, pneumonia, and bloodstream infections. They found that bacteria like E. coli and Klebsiella pneumoniae are increasingly resistant to standard antibiotics, including drugs like ceftriaxone and gentamicin. The study, published in The Lancet, is one of the largest ever to examine pediatric antibiotic resistance globally.
Why this matters for children like Harry
For children with weakened immune systems, the trend is especially alarming. Harry’s doctors have had to try multiple antibiotics to find one that works for each new infection. His mother, Sarah Booth, said the family has learned to expect longer hospital stays and more aggressive treatments. The study’s authors noted that children under five are particularly vulnerable because their immune systems are still developing, and they are more likely to be hospitalized with severe infections. In many low- and middle-income countries, resistance rates are highest, and access to second-line antibiotics is limited.
What the data shows about the scale of the problem
The researchers found that resistance to ceftriaxone, a common injectable antibiotic, rose from 18% to 36% in children with bloodstream infections over the study period. For gentamicin, resistance increased from 12% to 22%. The study also found that resistance rates were higher in hospital-acquired infections than in community-acquired ones. The authors called for better surveillance, more judicious use of antibiotics, and investment in new drugs and vaccines.
The findings underscore a quiet crisis that is already reshaping pediatric medicine. For families like Harry’s, the stakes are immediate and personal. Without effective antibiotics, routine infections can become life-threatening. The study’s global scope makes clear that no country is immune to this trend, and that children everywhere are paying the price.
